Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-01

FDA Approved: HETLIOZ LQ — Original Application (Vanda Pharmaceuticals Inc.)

View source ↗

Summary

FDA approval of Hetlioz LQ (tasimelteon) under the original NDA submitted by Vanda Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HETLIOZ LQ (tasimelteon)

Snippet

ORIG AP for HETLIOZ LQ (TASIMELTEON)